Pierre Verrelle
Overview
Explore the profile of Pierre Verrelle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
1098
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Portier L, Daira P, Fourmaux B, Heinrich S, Becerra M, Fouillade C, et al.
Int J Radiat Oncol Biol Phys
. 2024 Feb;
119(5):1481-1492.
PMID: 38340776
Purpose: The products of lipid peroxidation have been implicated in human diseases and aging. This prompted us to investigate the response to conventional (CONV) versus FLASH irradiation of oxylipins, a...
2.
Iturri L, Bertho A, Lamirault C, Brisebard E, Juchaux M, Gilbert C, et al.
Commun Med (Lond)
. 2023 Dec;
3(1):183.
PMID: 38102219
Background: Radiation-induced neurocognitive dysfunction is a major adverse effect of brain radiation therapy and has specific relevance in pediatric oncology, where serious cognitive deficits have been reported in survivors of...
3.
Douge A, Vituret C, Carraro V, Parry L, Coudy-Gandilhon C, Lemal R, et al.
HLA
. 2023 Oct;
103(1):e15252.
PMID: 37848366
T cell therapy strategies, from allogeneic stem cell transplantation toward genetically-modified T cells infusion, develop powerful anti-tumor effects but are often accompanied by side effects and their efficacy remains sometimes...
4.
Verrelle P, Gestraud P, Poyer F, Soria A, Tessier S, Lescure A, et al.
Int J Radiat Oncol Biol Phys
. 2023 Oct;
118(5):1294-1307.
PMID: 37778425
Purpose: High-throughput screening (HTS) platforms have been widely used to identify candidate anticancer drugs and drug-drug combinations; however, HTS-based identification of new drug-ionizing radiation (IR) combinations has rarely been reported....
5.
Proton FLASH Radiation Therapy and Immune Infiltration: Evaluation in an Orthotopic Glioma Rat Model
Iturri L, Bertho A, Lamirault C, Juchaux M, Gilbert C, Espenon J, et al.
Int J Radiat Oncol Biol Phys
. 2022 Dec;
116(3):655-665.
PMID: 36563907
Purpose: FLASH radiation therapy (FLASH-RT) is a promising radiation technique that uses ultrahigh doses of radiation to increase the therapeutic window of the treatment. FLASH-RT has been observed to provide...
6.
Porte J, Saint-Martin C, Frederic-Moreau T, Massiani M, Bozec L, Cao K, et al.
Biomedicines
. 2022 Sep;
10(9).
PMID: 36140349
Background: To analyze the outcomes of patients with brain metastases (BM) from non-small cell lung cancer (NSCLC) treated with immunotherapy (IT) and stereotactic radiotherapy (SRT) and to study the impact...
7.
Gaillard S, Adeniran S, Villa C, Jouinot A, Raffin-Sanson M, Feuvret L, et al.
Front Endocrinol (Lausanne)
. 2022 Sep;
13:975560.
PMID: 36105410
Objective: The management of giant pituitary tumors is complex, with few publications and recommendations. Consequently, patient's care mainly relies on clinical experience. We report here a first large series of...
8.
Silina L, Dufour F, Rapinat A, Reyes C, Gentien D, Maksut F, et al.
Int J Mol Sci
. 2022 Aug;
23(15).
PMID: 35955805
Bladder cancer is a common cancer; it is the tenth most common cancer in the world. Around one fourth of all diagnosed patients have muscle-invasive bladder cancer (MIBC), characterized by...
9.
Leyrat B, Khalill T, Lemaire J, Casile M, Molnar I, Dedieu V, et al.
Clin Transl Radiat Oncol
. 2022 Jun;
36:1-8.
PMID: 35733828
Background: The objective of our study was to report predictive factors of local control (LC) and radionecrosis (RN) of brain metastases (BM) of non-small cell lung carcinoma (NSCLC) treated by...
10.
Boiteux E, Guichet P, Masliantsev K, Montibus B, Vaurs-Barriere C, Gonthier-Gueret C, et al.
Int J Mol Sci
. 2022 May;
23(9).
PMID: 35563134
Glioblastomas represent approximatively half of all gliomas and are the most deadly and aggressive form. Their therapeutic resistance and tumor relapse rely on a subpopulation of cells that are called...